Buy GARDASIL 9 20 MCG RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN

GARDASIL 9 20 MCG is a recombinant human papillomavirus vaccine designed to help prevent certain types of HPV-related conditions. This intramuscular suspension is formulated to support immune response against specific HPV strains.

Strength

20 MCG

Pack Size

0.5ML

Manufacturer / TM Owner

MERCK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

GARDASIL 9 20 MCG is used to help prevent infections caused by certain types of human papillomavirus (HPV). This vaccine targets multiple HPV strains, which are commonly associated with various health conditions. It is often recommended as part of a broader vaccination strategy to reduce the risk of HPV-related illnesses.

Side Effects

Common effects of GARDASIL 9 20 MCG may include mild soreness, redness, or swelling at the injection site. Some individuals might experience temporary fatigue, headache, or muscle pain following vaccination. These effects are generally mild and short-lived.

Precautions & Warnings

Before receiving GARDASIL 9 20 MCG, inform your healthcare provider about any allergies or medical conditions. This vaccine should be administered by a healthcare professional. It is important to follow the recommended schedule for optimal effectiveness.

Avoid Interactions

GARDASIL 9 20 MCG may interact with certain medications or health conditions. Always inform your healthcare provider about any other vaccines or treatments you are currently receiving. Specific interactions should be discussed with a healthcare professional.

References

Frequently Asked Questions

GARDASIL 9 20 MCG is used to help prevent infections caused by certain types of human papillomavirus (HPV).

GARDASIL 9 20 MCG is administered as an intramuscular injection by a healthcare professional.

Common effects may include mild soreness, redness, or swelling at the injection site, as well as temporary fatigue or headache.

Always inform your healthcare provider about any other medications or treatments you are receiving to avoid potential interactions.

Individuals with a severe allergy to any component of the vaccine or those with certain medical conditions should consult a healthcare provider before receiving GARDASIL 9 20 MCG.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.